DK1825865T3 - Stabiliserede præparater af serin-endopeptidaser, deres fremstilling og anvendelse - Google Patents
Stabiliserede præparater af serin-endopeptidaser, deres fremstilling og anvendelseInfo
- Publication number
- DK1825865T3 DK1825865T3 DK07002494T DK07002494T DK1825865T3 DK 1825865 T3 DK1825865 T3 DK 1825865T3 DK 07002494 T DK07002494 T DK 07002494T DK 07002494 T DK07002494 T DK 07002494T DK 1825865 T3 DK1825865 T3 DK 1825865T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- serine endopeptidases
- stabilized preparations
- salts
- serine
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 3
- 102000003667 Serine Endopeptidases Human genes 0.000 title abstract 2
- 108090000083 Serine Endopeptidases Proteins 0.000 title abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 abstract 1
- 239000005695 Ammonium acetate Substances 0.000 abstract 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229940043376 ammonium acetate Drugs 0.000 abstract 1
- 235000019257 ammonium acetate Nutrition 0.000 abstract 1
- 229960001230 asparagine Drugs 0.000 abstract 1
- 235000009582 asparagine Nutrition 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21006—Coagulation factor Xa (3.4.21.6)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006008613A DE102006008613A1 (de) | 2006-02-24 | 2006-02-24 | Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1825865T3 true DK1825865T3 (da) | 2009-04-20 |
Family
ID=38062568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07002494T DK1825865T3 (da) | 2006-02-24 | 2007-02-06 | Stabiliserede præparater af serin-endopeptidaser, deres fremstilling og anvendelse |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8124737B2 (fr) |
| EP (1) | EP1825865B1 (fr) |
| JP (1) | JP5096759B2 (fr) |
| AT (1) | ATE420662T1 (fr) |
| CA (1) | CA2579458C (fr) |
| DE (2) | DE102006008613A1 (fr) |
| DK (1) | DK1825865T3 (fr) |
| ES (1) | ES2318803T3 (fr) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11229746B2 (en) | 2006-06-22 | 2022-01-25 | Excelsior Medical Corporation | Antiseptic cap |
| US9078992B2 (en) | 2008-10-27 | 2015-07-14 | Pursuit Vascular, Inc. | Medical device for applying antimicrobial to proximal end of catheter |
| US9333280B2 (en) | 2009-02-25 | 2016-05-10 | Teleflex Medical Incorporated | Stabilized enzyme compositions |
| US8545459B2 (en) | 2009-02-25 | 2013-10-01 | Teleflex Medical Incorporated | Stabilized enzyme compositions |
| US9388452B2 (en) * | 2010-04-08 | 2016-07-12 | Baxalta Incorporated | Methods for modeling protein stability |
| US10166381B2 (en) | 2011-05-23 | 2019-01-01 | Excelsior Medical Corporation | Antiseptic cap |
| WO2012167271A1 (fr) * | 2011-06-02 | 2012-12-06 | Baxter International Inc. | Formulations de furine recombinante |
| WO2012174127A1 (fr) * | 2011-06-17 | 2012-12-20 | Alvine Pharmaceuticals, Inc. | Protéases destinées à dégrader le gluten |
| EP3714932A1 (fr) | 2011-07-12 | 2020-09-30 | ICU Medical, Inc. | Dispositif pour l'administration d'agent antimicrobien dans un cathéter transdermique |
| JP6174367B2 (ja) * | 2013-04-26 | 2017-08-02 | 株式会社Ｌｓｉメディエンス | トロンビン含有試薬及び測定方法 |
| JP6185662B2 (ja) | 2013-09-30 | 2017-08-23 | テレフレックス メディカル インコーポレイテッド | 安定化酵素組成物 |
| WO2015168677A1 (fr) | 2014-05-02 | 2015-11-05 | Excelsior Medical Corporation | Emballage de bande pour bouchon antiseptique |
| FR3035120B1 (fr) * | 2015-04-15 | 2020-02-07 | Arcadophta | Composition de plasminogenase immobilisee, procede de preparation, utilisation et dispositif comprenant une telle composition |
| CA2982456A1 (fr) | 2015-05-08 | 2016-11-17 | Icu Medical, Inc. | Raccords medicaux configures pour recevoir des emetteurs d'agents therapeutiques |
| JP2018524067A (ja) | 2015-06-11 | 2018-08-30 | アットウィル メディカル ソルーションズ インコーポレイテッド | アンチトロンビン−ヘパリン組成物を利用する医療機器、システムおよび方法 |
| AU2017341782B2 (en) | 2016-10-14 | 2023-03-16 | Icu Medical, Inc. | Sanitizing caps for medical connectors |
| WO2018204206A2 (fr) | 2017-05-01 | 2018-11-08 | Icu Medical, Inc. | Raccords de fluide médical et procédés pour fournir des additifs dans des conduites de fluide médical |
| US11400195B2 (en) | 2018-11-07 | 2022-08-02 | Icu Medical, Inc. | Peritoneal dialysis transfer set with antimicrobial properties |
| US11541220B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Needleless connector with antimicrobial properties |
| US11534595B2 (en) | 2018-11-07 | 2022-12-27 | Icu Medical, Inc. | Device for delivering an antimicrobial composition into an infusion device |
| US11517732B2 (en) | 2018-11-07 | 2022-12-06 | Icu Medical, Inc. | Syringe with antimicrobial properties |
| US11541221B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Tubing set with antimicrobial properties |
| US11433215B2 (en) | 2018-11-21 | 2022-09-06 | Icu Medical, Inc. | Antimicrobial device comprising a cap with ring and insert |
| CN111500563B (zh) * | 2020-05-08 | 2023-10-13 | 华兰生物工程重庆有限公司 | 一种从人血浆中纯化人凝血因子ⅶ的方法 |
| BR112023002738A2 (pt) * | 2020-08-14 | 2023-05-02 | Steuben Foods Inc | Leite à base de vegetais que compreende proteína hidrolisada e composições de cátion divalentes com melhor sabor e estabilidade |
| EP4255552A1 (fr) | 2020-12-07 | 2023-10-11 | ICU Medical, Inc. | Capuchons, systèmes et procédés de dialyse péritonéale |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3531778A1 (de) * | 1985-09-06 | 1987-03-12 | Behringwerke Ag | Verfahren zur bestimmung von proteaseinhibitoren |
| IL86417A (en) * | 1987-05-22 | 1992-09-06 | Armour Pharma | Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers |
| DK223389D0 (da) * | 1989-05-05 | 1989-05-05 | Ferrosan As | Saarsvamp |
| US5308755A (en) * | 1992-06-08 | 1994-05-03 | Research Corporation Technologies, Inc. | Method for measuring heparin |
| KR100258377B1 (ko) * | 1993-05-28 | 2000-06-01 | 존 더블유. 아담슨 엠. 디. | 생물학적 조성물의 살균 방법 및 이에 의해 생성된 생성물 |
| DE4325872C1 (de) * | 1993-08-02 | 1994-08-04 | Immuno Ag | Virusinaktivierte Faktor Xa-Präparation |
| DE4416166C2 (de) | 1994-05-06 | 1997-11-20 | Immuno Ag | Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen |
| DE19856443A1 (de) * | 1998-12-08 | 2000-06-21 | Centeon Pharma Gmbh | Stabilisiertes Antithrombin III-Präparat |
| US20010031721A1 (en) * | 1999-05-05 | 2001-10-18 | Chandra Webb | Highly concentrated, lyophilized, and liquid factor IX formulations |
| DE10022092A1 (de) * | 2000-05-08 | 2001-11-15 | Aventis Behring Gmbh | Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung |
| JP2007509982A (ja) * | 2003-10-29 | 2007-04-19 | アルタス ファーマシューティカルズ インコーポレイテッド | 血漿コレシストキニン（ｃｃｋ）濃度を制御するための非膵臓プロテアーゼおよび痛みを処置するための非膵臓プロテアーゼ |
| KR20140093711A (ko) * | 2003-12-19 | 2014-07-28 | 노보 노르디스크 헬스 케어 악티엔게젤샤프트 | 인자 ｖｉｉ 폴리펩티드의 안정화된 조성물 |
-
2006
- 2006-02-24 DE DE102006008613A patent/DE102006008613A1/de not_active Withdrawn
-
2007
- 2007-02-06 AT AT07002494T patent/ATE420662T1/de active
- 2007-02-06 DE DE502007000371T patent/DE502007000371D1/de active Active
- 2007-02-06 DK DK07002494T patent/DK1825865T3/da active
- 2007-02-06 EP EP07002494A patent/EP1825865B1/fr active Active
- 2007-02-06 ES ES07002494T patent/ES2318803T3/es active Active
- 2007-02-22 CA CA2579458A patent/CA2579458C/fr active Active
- 2007-02-23 JP JP2007043181A patent/JP5096759B2/ja active Active
- 2007-02-23 US US11/709,747 patent/US8124737B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2579458C (fr) | 2015-08-11 |
| US8124737B2 (en) | 2012-02-28 |
| EP1825865A2 (fr) | 2007-08-29 |
| DE502007000371D1 (de) | 2009-03-05 |
| US20070231315A1 (en) | 2007-10-04 |
| EP1825865A3 (fr) | 2007-12-12 |
| DE102006008613A1 (de) | 2007-08-30 |
| CA2579458A1 (fr) | 2007-08-24 |
| EP1825865B1 (fr) | 2009-01-14 |
| ES2318803T3 (es) | 2009-05-01 |
| JP2007222169A (ja) | 2007-09-06 |
| JP5096759B2 (ja) | 2012-12-12 |
| ATE420662T1 (de) | 2009-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1825865T3 (da) | Stabiliserede præparater af serin-endopeptidaser, deres fremstilling og anvendelse | |
| DK3911648T3 (da) | 6'-[[(1s,3s)-3-[[5-(difluormethoxy)-2-pyrimidinyl]amino]cyclopentyl]amino][1(2h),3'-bipyridin]-2-on som pcsk9-hæmmer og fremgangsmåder til anvendelse deraf | |
| DK1698640T4 (da) | Fremgangsmåde til stabilisering af antistof og antistofpræparat som stabiliseret opløsning. | |
| NO20076592L (no) | Stabilt aktivt-stoffkompleks av salter av o-acetylsalicylsyre med basiske aminosyrer og glycin | |
| BRPI0510674A (pt) | variantes fc otimizadas | |
| NO20084893L (no) | Lyofiliserte terapeutiske peptistoffpreparater | |
| BRPI0720646A2 (pt) | Sensor de geolocalização portátil, método para localizar um emissor de interesse (eoi) utilizando pelo menos um sensor de geolocalização portátil e sistema para localização de um emissor de interesse (eoi) | |
| AU2011208075B2 (en) | Stabilized antibody-containing liquid formulations | |
| EA200802005A1 (ru) | Стабилизированная связывающая молекула на основе стабилизированной молекулы scfv (варианты) и варианты получения и использования вышеназванных стабилизированных молекул | |
| DK1449917T3 (da) | Fremgangsmåde til L-aminosyrefremstilling under anvendelse af Escherichia | |
| DK2147098T3 (da) | Anvendelse af proteinhydrolysater til stabilisering af metalloprotease-detergent-formuleringer | |
| BR112012004391A2 (pt) | adesivos de soja/ureia desnaturados com ácido estável e métodos para sua fabricação. | |
| DK1896006T3 (da) | Fremstillingmetode for entacapon-holdige granuler til orale doseringsformet | |
| NO20090574L (no) | Nye proteinkonjugater og fremgangsmater for fremstilling derav | |
| EA200970896A1 (ru) | ТВЕРДАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ ПРОИЗВОДНОЕ БЕНЗИМИДАЗОЛ-7-КАРБОКСИЛАТА И pH РЕГУЛИРУЮЩИЙ АГЕНТ | |
| FR2921572B1 (fr) | Dispositif de conformation circulaire d'une piece de revolution, notamment un carter d'echappement d'une turbomachine | |
| EA200802319A1 (ru) | Способ и устройство для ремонта элементов конструкции | |
| ATE483919T1 (de) | Hülse | |
| TW200736576A (en) | Alignment correction system and methods of use thereof | |
| BRPI0907103A2 (pt) | método para tratamento de dentes sensíveis, composição de selante dental, e, uso de um aminoácido básico em forma livre ou em forma de sal. | |
| BRPI0913178A2 (pt) | Método para produzir um hidrolisado de caseína, hidrolisado de caseína, e, uso de hidrolisado de caseína | |
| NO20082989L (no) | Fremstiling av gamma-aminosyrer som har affinitet for alfa-2-deltaproteinet | |
| DK1988090T3 (da) | Imidazol-5-carboxylsyrederivater, fremgangsmåder til fremstilling af disse og anvendelse deraf | |
| BRPI0913174A2 (pt) | Método para produzir um hidrolisado de proteína de trigo, hidrolisado de proteína de trigo, e, uso de um hidrolisado de proteína de trigo. | |
| DK2251579T3 (da) | Spændebånd |